Unknown

Dataset Information

0

Exocrine pancreas function is impaired in adult relatives of patients with type 1 diabetes.


ABSTRACT:

Aims

Alterations of the exocrine pancreas have been reported in type 1 diabetes, but their contribution to the pathogenesis of the disease is poorly understood. Here, we investigated markers of exocrine pancreas dysfunction in individuals at-risk of developing type 1 diabetes.

Methods

Serum P-amylase and lipase levels were assessed in samples obtained from healthy controls, patients with new onset type 1 diabetes, relatives participating to the TrialNet Pathway to Prevention who were, at blood collection, autoantibody negative or positive for a single autoantibody (low-risk individuals), and positive for multiple autoantibodies (high-risk individuals). Linear mixed models were adopted to estimate variation of pancreatic enzymes among the groups and to evaluate the influence of high-risk HLA genotypes and residual beta cell function on exocrine pancreas function.

Results

In adults, but not children, reduced levels of P-amylase and lipase were shown in at-risk individuals, including (for P-amylase levels only) those at low-risk, and in T1Dnew. Furthermore, while high-risk HLA genotypes negatively affected P-amylase levels in autoantibody negative adult individuals, fasting C-peptide levels did not correlate with pancreatic enzyme levels.

Conclusions

Exocrine pancreas dysfunction precedes the onset of type 1 diabetes in adult at-risk individuals and may be unrelated to fasting C-peptide levels.

SUBMITTER: Giovenzana A 

PROVIDER: S-EPMC8917021 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Aims</h4>Alterations of the exocrine pancreas have been reported in type 1 diabetes, but their contribution to the pathogenesis of the disease is poorly understood. Here, we investigated markers of exocrine pancreas dysfunction in individuals at-risk of developing type 1 diabetes.<h4>Methods</h4>Serum P-amylase and lipase levels were assessed in samples obtained from healthy controls, patients with new onset type 1 diabetes, relatives participating to the TrialNet Pathway to Prevention who w  ...[more]

Similar Datasets

| S-EPMC10888906 | biostudies-literature
| S-EPMC9044038 | biostudies-literature
| S-EPMC6341284 | biostudies-literature
| S-EPMC6948281 | biostudies-literature
| S-EPMC11251461 | biostudies-literature
| S-EPMC7980193 | biostudies-literature
| S-EPMC6301765 | biostudies-literature
| S-EPMC7567597 | biostudies-literature
| S-EPMC8577826 | biostudies-literature
| S-EPMC4207385 | biostudies-literature